NovaLisa® SARS-CoV-2 IgA 96 det.

NovaLisa® SARS-CoV-2 IgA 96 det.

NovaLisa® SARS-CoV-2 IgG 96 det.

The NovaLisa® SARS-CoV-2 IgG ELISA kit is intended for the qualitative detection of IgG class antibodies to the SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The assay is CE-IVD marked The ELISA antibody detection assays are an ideal supplement for the direct pathogen detection and are a valuable tool for epidemiological studies.

The ELISA kits demonstrate high sensitivity and specificity: antibodies were detected in all tested samples from patients PCR positive for SARS-CoV-2 12 days after symptom onset (100% sensitivity in this patient group). The specificity is >98%.*
* Initial testing on more than 300 samples. Please refer to the product inserts for more details.


If you are from Germany, please visit this product page.
If you are from the US, please visit this product page.

The NovaLisa® SARS-CoV-2 IgG ELISA kit is intended for the qualitative detection of antibodies to the SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The assay is CE-IVD marked.

Assay Features

 Separate Detection of IgG antibodies
 SARS-CoV-2 Nucleocapsid recombinant antigen
 Ideal complement to RT-PCR
 Ready-to-use controls
 Results in 2 hours
 Assay procedure is easy to automate
 Works on any open ELISA system (protocols available)
 CE-IVD

More Information
SKU COVG0940
Test principle Enzyme-linked Immunosorbent Assay
Format Microtiter plate with 96 wells
Incubation Time 2 hours
Storage 2–8°C